SCHEMBL269852

SCHEMBL269852

CCCCCCCC(CCCC)OC(=O)c1ccccc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
ALDH1A1 P00352 6/20 0.56
NAAA Q02083 1/20 0.50
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50
TSHR P16473 4/20 0.48
TDP1 Q9NUW8 3/20 0.46
CYP3A4 P08684 2/20 0.46
CA2 P00918 1/20 0.46
TP53 P04637 1/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 2/20 0.43
POLB P06746 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5145730 1.00 LMNA (0.58) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL5147089 1.00 LMNA (0.58) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL17907447 0.99 ALDH1A1 (0.57) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL22684920 0.99 ALDH1A1 (0.57) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL22684928 0.99 ALDH1A1 (0.57) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL1498192 0.99 ALDH1A1 (0.57) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL17907455 0.99 ALDH1A1 (0.57) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL296634 0.99 ALDH1A1 (0.57) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL5143900 0.96 ALDH1A1 (0.54) LMNAALDH1A1NAAAPRSS1PRSS2
SCHEMBL10593824 0.94 ALDH1A1 (0.53) LMNAALDH1A1NAAAPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1838 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12616647-B2 Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles L'OREAL (FR) 2026-05-05 US claimed
US-12589059-B2 Mineral sunscreen compositions with high SPF and shelf stability L'OREAL (FR) 2026-03-31 US claimed
US-20260083659-A1 SUNSCREEN COMPOSITIONS AND METHODS OF USE MARY KAY INC. (US) 2026-03-26 US claimed
EP-4673106-A1 COSMETIC COMPOSITION WITH ZINC OXIDE AND BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE L'OREAL (FR) 2026-01-07 EP claimed
US-12485072-B1 Eco-friendly and biocompatible hybrid nanomaterials in sunscreen IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) 2025-12-02 US claimed
EP-4251121-B1 TOPICAL COMPOSITION DSM IP ASSETS BV (NL) 2025-10-01 EP claimed
EP-4608519-A1 UV FILTER COMPOSITION COMPRISING TRITERPENES, EMOLLIENTS AND INORGANIC UV-FILTERS AAK AB (publ) (SE) 2025-09-03 EP claimed
EP-4609918-A2 TOPICAL COMPOSITION DSM IP Assets B.V. (NL) 2025-09-03 EP claimed
US-20250205128-A1 COSMETIC COMPOSITIONS AND METHODS OF USING SAME MARY KAY INC. (US) 2025-06-26 US claimed
WO-2025132297-A1 SUNSCREEN COMPOSITIONS DSM IP ASSETS B.V. (NL) 2025-06-26 WO claimed
WO-2003053390-A1 COSMETIC AND DERMATOLOGICAL LIGHT PROTECTION FORMULATIONS HAVING A CONTENT OF BENZOXAZOL DERIVATIVES BEIERSDORF AG (DE) 2003-07-03 WO claimed
EP-1216685-A2 Personal care compositions Johnson & Johnson Consumer Companies, Inc. (US) 2002-06-26 EP claimed
US-6409997-B1 LESS THAN 5%, BY WEIGHT, OF OIL. NEUTROGENA CORPORATION 2002-06-25 US claimed
US-20020035046-A1 Personal care compositions JOHNSON & JOHNSON CONSUMER INC. 2002-03-21 US claimed
WO-2002017873-A1 SUNSCREEN COMPOSITIONS CONTAINING A DIBENZOYLMETHANE DERIVATIVE AND A TRIAZINE DERIVATIVE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-03-07 WO claimed
WO-2001001949-A9 CLEANSING COMPOSITIONS JOHNSON & JOHNSON CONSUMER (US) 2001-03-22 WO claimed
WO-2001001949-A1 CLEANSING COMPOSITIONS JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) 2001-01-11 WO claimed
EP-0930063-A2 Skin care and sunscreen composition The C.P. Hall Company (US) 1999-07-21 EP claimed
US-5849273-A Skin care and sunscreen composition containing dibenzoylmethane derivative, e.g., parsol® 1789, and C12, C16, C18 branched chain hydroxybenzoate and/or C12, C16 branched chain benzoate stabilizers/solubilizers THE C. P. HALL COMPANY (US) 1998-12-15 US claimed
US-5788954-A ULTRAVIOLET FILTER COMPOUNDS FOR PROTECTIVE SKIN LOTIONS THE C. P. HALL COMPANY (US) 1998-08-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035046-A1 Personal care compositions CUTA, DSG1, KRT18 LMNA 1546/4885ALDH1A1 2534/4885NAAA 3000/4885
US-12616647-B2 Non-pulverulent antisun composition comprising a polar oil phase and hydrophobic silica aerogel particles SMURF1, EBP, SPTLC3 LMNA 1535/4885ALDH1A1 3993/4885NAAA 4080/4885
US-20260083659-A1 SUNSCREEN COMPOSITIONS AND METHODS OF USE CUTA, TYR, SUN2 LMNA 4254/4885ALDH1A1 327/4885NAAA 4743/4885
US-12589059-B2 Mineral sunscreen compositions with high SPF and shelf stability CUTA, SLC39A3, SLC30A7 LMNA 917/4885ALDH1A1 847/4885NAAA 3018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.